Register entry
- Registered sites
- 0
- Active NDC listings
- 11
- Labeller names
- 5
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
1111 active NDC listings: 11 bulk ingredient. By marketing category: BULK INGREDIENT 10, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING 1.
| Dosage form | NDCs |
|---|---|
| powder | 11 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| uquifa mexico, s.a. de c.v. | 3 |
| uquifa mexico, s.a. de c.v. | 3 |
| uquifa mexico, s.a. de c.v. | 2 |
| uquifa mexico, s.a. de c.v. | 2 |
| uquifa mexico, s.a. de c.v. | 1 |
Catalogue
Marketed products
11| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Cinacalcet HCI | powder | 52286-0023BULK INGREDIENT |
| - | Halofantrine Hydrochloride | powder | 52286-4195BULK INGREDIENT |
| - | Levofloxacin Hemihydrate | powder | 52286-0016BULK INGREDIENT |
| - | Oxantel Pamoate | powder | 52286-0026BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Pregabalin | powder | 52286-0022BULK INGREDIENT |
| - | Rabeprazole Sodium | powder | 52286-0017BULK INGREDIENT |
| - | Rivaroxaban | powder | 52286-0025BULK INGREDIENT |
| - | Telmisartan | powder | 52286-0024BULK INGREDIENT |
| - | Venlafaxine Hydrochloride | powder | 52286-0006BULK INGREDIENT |
| - | Zolpidem Tartrate | powder | 52286-0004BULK INGREDIENT |
| - | carisoprodol | powder | 52286-0021BULK INGREDIENT |
Compare
Other companies listing cinacalcet hci
- PCAS Finland Oy1 site · 20 NDC
Enquiry
Common questions
- Is UQUIFA Mexico, S.A. de C.V. FDA approved?
- UQUIFA Mexico, S.A. de C.V. holds no registered establishment of its own; 11 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does UQUIFA Mexico, S.A. de C.V. make?
- 11 products are listed under UQUIFA Mexico, S.A. de C.V. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.